Suvi Kuivanen

5.7k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Suvi Kuivanen is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Parasitology. According to data from OpenAlex, Suvi Kuivanen has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 12 papers in Public Health, Environmental and Occupational Health and 5 papers in Parasitology. Recurrent topics in Suvi Kuivanen's work include Viral Infections and Vectors (12 papers), Mosquito-borne diseases and control (12 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Suvi Kuivanen is often cited by papers focused on Viral Infections and Vectors (12 papers), Mosquito-borne diseases and control (12 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Suvi Kuivanen collaborates with scholars based in Finland, United States and Germany. Suvi Kuivanen's co-authors include Olli Vapalahti, Anne J. Jääskeläinen, Teemu Smura, Lev Levanov, Essi M. Korhonen, Gilbert Vézina, Robert S. Lanciotti, Cheng‐Ying Ho, Andrew K. Hennenfent and Roberta L. DeBiasi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Scientific Reports.

In The Last Decade

Suvi Kuivanen

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities

2016 608 citations Rita W. Driggers, Cheng‐Ying Ho et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Suvi Kuivanen

Since Specialization

Citations

This map shows the geographic impact of Suvi Kuivanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi Kuivanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi Kuivanen more than expected).

Fields of papers citing papers by Suvi Kuivanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvi Kuivanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi Kuivanen. The network helps show where Suvi Kuivanen may publish in the future.

Co-authorship network of co-authors of Suvi Kuivanen

This figure shows the co-authorship network connecting the top 25 collaborators of Suvi Kuivanen. A scholar is included among the top collaborators of Suvi Kuivanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvi Kuivanen. Suvi Kuivanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanobody engineering for SARS-CoV-2 neutralization and detection 2024 ·Microbiology Spectrum ·(unknown), Suvi Kuivanen, (unknown), Ravi Kant, Lauri Kareinen, (unknown), Tomas Strandin, Tarja Sironen, Jussi Hepojoki, Vivek Sharma, Petri Saviranta, Anja Kipar, Olli Vapalahti, Juha T. Huiskonen, Ilona Rissanen	4
2	Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome 2024 ·Antiviral Research ·(unknown), Suvi Kuivanen, Swapnil Potdar, Antti Hassinen, (unknown), Ina Pöhner, (unknown), Laura Turunen, (unknown), Leonóra Szirovicza, Kirsi Savijoki, Jani Saarela, Päivi Tammela, Lassi Paavolainen, Antti Poso, Markku Varjosalo, Olli Kallioniemi, Vilja Pietiäinen, Olli Vapalahti	2
3	Exposure to urban particulate matter alters responses of olfactory mucosal cells to SARS-CoV-2 infection 2024 ·Environmental Research ·(unknown), Suvi Kuivanen, (unknown), Alexey М. Afonin, (unknown), (unknown), (unknown), Anne M. Koivisto, Elina Penttilä, Heikki Löppönen, Pasi Jalava, Olli Vapalahti, Giuseppe Balistreri, Riikka Lampinen, Katja M. Kanninen	0
4	Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients 2024 ·Virus Research ·Xiaobo Huang, Jonas Kantonen, Kirsten Nowlan, (unknown), (unknown), Suvi Kuivanen, Nelli Heikkilä, (unknown), Anu Kantele, Olli Vapalahti, Liisa Myllykangas, Santtu Heinonen, Mikko I. Mäyränpää, Tomas Strandin, Eliisa Kekäläinen	3
5	Human-derived air–liquid interface cultures decipher Alzheimer’s disease–SARS-CoV-2 crosstalk in the olfactory mucosa 2023 ·Journal of Neuroinflammation ·(unknown), Suvi Kuivanen, Riikka Lampinen, (unknown), Tomáš Hron, (unknown), Ravi Ojha, Zdeněk Krejčík, Liudmila Saveleva, (unknown), (unknown), Anne M. Koivisto, Elina Penttilä, Heikki Löppönen, Prateek Singh, Jan Topinka, Olli Vapalahti, (unknown), Giuseppe Balistreri, Katja M. Kanninen	5
6	Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein 2022 ·Proceedings of the National Academy of Sciences ·Kailu Yang, Chuchu Wang, Alex J.B. Kreutzberger, Ravi Ojha, Suvi Kuivanen, Sergio Couoh‐Cardel, Serena Muratcioğlu, Timothy J. Eisen, K. Ian White, Richard G. Held, Subu Subramanian, (unknown), Richard A. Pfuetzner, Luis Esquivies, Catherine A. Doyle, John Kuriyan, Olli Vapalahti, Giuseppe Balistreri, Tomas Kirchhausen, Axel T. Brünger	27
7	Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection 2022 ·Journal of Virological Methods ·Maarit J. Ahava, Satu Kurkela, Suvi Kuivanen, Maija Lappalainen, Hanna Jarva, Anne J. Jääskeläinen	14
8	Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro 2022 ·Frontiers in Pharmacology ·Senem Merve Fred, Suvi Kuivanen, (unknown), Plínio Casarotto, Lev Levanov, Kalle Saksela, Olli Vapalahti, Eero Ċastrén	35
9	Characterization of low-density granulocytes in COVID-19 2021 ·PLoS Pathogens ·(unknown), Pirkka T. Pekkarinen, (unknown), Kirsten Nowlan, (unknown), (unknown), Suvi Kuivanen, (unknown), Sointu Mero, Sari H. Pakkanen, Santtu Heinonen, Anu Kantele, Olli Vapalahti, Eliisa Kekäläinen, Tomas Strandin	59
10	Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation 2021 ·Briefings in Bioinformatics ·Angela Serra, Michele Fratello, Antonio Federico, Ravi Ojha, (unknown), Ervin Tasnádi, Luca Cattelani, Giusy del Giudice, Pia Kinaret, Laura Aliisa Saarimäki, (unknown), Suvi Kuivanen, Vincenzo Cerullo, Olli Vapalahti, Péter Horváth, A. Di Lieto, Jari Yli‐Kauhaluoma, Giuseppe Balistreri, Dario Greco	14
11	Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays 2021 ·Viruses ·Jenni Virtanen, Ruut Uusitalo, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura, Suvi Kuivanen, Sari H. Pakkanen, Sointu Mero, (unknown), (unknown), Anu Kantele, (unknown), Klaus Hedman, Jussi Hepojoki, Tarja Sironen, Eili Huhtamo, Olli Vapalahti	7
12	Molecular detection and phylogenetic analysis of Borrelia miyamotoi strains from ticks collected in the capital region of Finland 2020 ·Ticks and Tick-borne Diseases ·Fathiah Zakham, Anne J. Jääskeläinen, (unknown), Jani J. Sormunen, Ruut Uusitalo, Teemu Smura, (unknown), Suvi Kuivanen, Tarja Sironen, Olli Vapalahti	7
13	Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation 2020 ·Journal of Clinical Virology ·Anne J. Jääskeläinen, Suvi Kuivanen, Eliisa Kekäläinen, Maarit J. Ahava, Raisa Loginov, Hannimari Kallio‐Kokko, Olli Vapalahti, Hanna Jarva, Satu Kurkela, Maija Lappalainen	123
14	Asian and African lineage Zika viruses show differential replication and innate immune responses in human dendritic cells and macrophages 2019 ·Scientific Reports ·Pamela Österlund, Miao Jiang, (unknown), Suvi Kuivanen, (unknown), Laura Kakkola, Rickard Lundberg, Krister Melén, Miša Korva, Tatjana Avšič‐Županc, Olli Vapalahti, Ilkka Julkunen	15
15	Recent establishment of tick-borne encephalitis foci with distinct viral lineages in the Helsinki area, Finland 2019 ·Emerging Microbes & Infections ·Teemu Smura, Elina Tonteri, Anu Jääskeläinen, (unknown), Suvi Kuivanen, Otso Huitu, Lauri Kareinen, (unknown), Ruut Uusitalo, Tuula Hannila‐Handelberg, Liina Voutilainen, Simo Nikkari, Tarja Sironen, Jussi Sane, (unknown), Olli Vapalahti	26
16	Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism 2017 ·Antiviral Research ·Suvi Kuivanen, Maxim M. Bespalov, Jatin Nandania, Aleksandr Ianevski, Vidya Velagapudi, Jef K. De Brabander, Denis E. Kainov, Olli Vapalahti	66
17	Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities breakdown → 2016 ·New England Journal of Medicine ·Rita W. Driggers, Cheng‐Ying Ho, Essi M. Korhonen, Suvi Kuivanen, Anne J. Jääskeläinen, Teemu Smura, Avi Z. Rosenberg, David A. Hill, Roberta L. DeBiasi, Gilbert Vézina, Julia Timofeev, Fausto J. Rodríguez, Lev Levanov, (unknown), Preetha Iyengar, Andrew K. Hennenfent, Richard D. Kennedy, Robert S. Lanciotti, Adré du Plessis, Olli Vapalahti	608
18	The Presence and Seroprevalence of Arthropod-Borne Viruses in Nasiriyah Governorate, Southern Iraq: A Cross-Sectional Study 2016 ·American Journal of Tropical Medicine and Hygiene ·(unknown), Teemu Smura, Suvi Kuivanen, Eili Huhtamo, Satu Kurkela, Niina Putkuri, (unknown), Haider Al‐Hello, Olli Vapalahti	19
19	Novel flaviviruses from mosquitoes: Mosquito-specific evolutionary lineages within the phylogenetic group of mosquito-borne flaviviruses 2014 ·Virology ·Eili Huhtamo, Shelley Cook, Grégory Moureau, Nathalie Y. Uzcátegui, Tarja Sironen, Suvi Kuivanen, Niina Putkuri, Satu Kurkela, Ralph E. Harbach, Andrew E. Firth, Olli Vapalahti, Ernest A. Gould, Xavier de Lamballerie	56
20	Identification of linear human B-cell epitopes of tick-borne encephalitis virus 2014 ·Virology Journal ·Suvi Kuivanen, Jussi Hepojoki, Sirkka Vene, Antti Vaheri, Olli Vapalahti	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact